Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer.
- Published in:
- Oncogene, 2009, v. 28, n. 31, p. 2829, doi. 10.1038/onc.2009.134
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2009 AND VI 28 AND IP 31
Results: 7
1
2
An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.
- Published in:
- Oncogene, 2009, v. 28, n. 31, p. 2773, doi. 10.1038/onc.2009.135
- By:
- Publication type:
- Article
3
Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma.
- Published in:
- Oncogene, 2009, v. 28, n. 31, p. 2821, doi. 10.1038/onc.2009.137
- By:
- Publication type:
- Article
4
Anchorage-independent cell growth signature identifies tumors with metastatic potential.
- Published in:
- Oncogene, 2009, v. 28, n. 31, p. 2796, doi. 10.1038/onc.2009.139
- By:
- Publication type:
- Article
5
BubR1 localizes to centrosomes and suppresses centrosome amplification via regulating Plk1 activity in interphase cells.
- Published in:
- Oncogene, 2009, v. 28, n. 31, p. 2806, doi. 10.1038/onc.2009.141
- By:
- Publication type:
- Article
6
Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells.
- Published in:
- Oncogene, 2009, v. 28, n. 31, p. 2784, doi. 10.1038/onc.2009.142
- By:
- Publication type:
- Article
7
The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility.
- Published in:
- Oncogene, 2009, v. 28, n. 31, p. 2839, doi. 10.1038/onc.2009.146
- By:
- Publication type:
- Article